CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Detroit Lions Seed 50/50 Raffle With $30,000 For Monday Night Football

View Comments
PHILADELPHIA, PA - DECEMBER 8: Wide receiver Jeremy Ross #12 celebrates with teammates after scoring a touchdown on a 98 yard kick return against the Philadelphia Eagles in the fourth quarter during a game at Lincoln Financial Field on December 8, 2013 in Philadelphia, Pennsylvania. (Photo by Rich Schultz /Getty Images)

PHILADELPHIA, PA – DECEMBER 8: Wide receiver Jeremy Ross #12 celebrates with teammates after scoring a touchdown on a 98 yard kick return against the Philadelphia Eagles in the fourth quarter during a game at Lincoln Financial Field on December 8, 2013 in Philadelphia, Pennsylvania. (Photo by Rich Schultz /Getty Images)

DETROIT – The Detroit Lions have announced they will seed the Game On Cancer 50/50 raffle pot with $30,000 for Monday Night Football, Dec. 16.

The raffle will begin before doors open in the Pride Plaza on Brush presented by Bud Light at 5:00 p.m. This free event is open to all fans, including non-ticket holders. All fans are welcome to participate in the 50/50 raffle and do not need to be a game-ticket holder to enter, nor do they need to be present to win. The winning number and final pot total will be posted on DetroitLions.com/5050.

Raffle proceeds benefit Henry Ford Health System’s Josephine Ford Cancer Institute, its Game On Cancer campaign and the Detroit Lions’ Living for the City philanthropic initiative.

This season, the Game On Cancer 50/50 raffle has exceeded expectations, largely in part to fan participation. Since bringing mobile, electronic 50/50 raffling to Ford Field, the Game On Cancer raffle has grossed almost a half million dollars. The last three games have grossed more than $100,000 each.

For more information about Game On Cancer, please visit GameOnCancer.com, and for information about Living for the City, please visit DetroitLions.com/community.

View Comments
blog comments powered by Disqus